Tiny_logo_white you are in demo mode.    to view your own genetic profile, order your scan now.

Site search

  • your results
  • background
  • risk and prevention
  • scientific details
  • research
  • discussion
  • >>

The most recent disease risk model uses 1 variant that was not measured in your genetic scan and therefore the results presented here may not be as accurate as possible. See the table in scientific details for further information.

Recent changes:
Dec 08 2011, 11:35 AM Added one variant for Europeans
May 10 2011, 02:20 PM Added five variants for individuals of European descent

Bladder Cancer

Urinary bladder cancer is the 6th most common type of cancer in the United States.

Please select a gender or population for your results.

This disease has different risk results depending on population or gender. Below you can select the ones you belong to.

Ethnicity:  European ancestry

Gender:   

Results can vary according to population and/or gender. Results currently based on:

European ancestry

Trait_world_map

Male

Trait_male_female

change


Blca
According to the selected literature, the relative genetic risk calculated from your genotype for males of European ancestry is 1.13. This corresponds to a 4.6% lifetime risk of developing bladder cancer, which is 13% greater than for males of European ancestry in general (source) . Note that these calculations may not include all risk factors.
The lifetime risk of your type
It is estimated that 46 of every 1000 males of European ancestry with your genotype variants develop this disease in their lifetime.
Blca
The average lifetime risk
On average, about 41 of every 1000 males of European ancestry develop this disease in their lifetime.
Blca

Consult with our experts

Need something clarified? If so, please feel free to contact our experts. Based on the nature of you question we may refer you for professional medical or genetic counselling. In the US we offer to those who need it the services of Informed Medical Decisions Inc., a nationwide-network of licensed genetic experts.

ask a question about Bladder Cancer

Keep in mind

These are the results of calculations comparing your genetic sequence to sequence of participants in studies published in the world literature on genetic risk for this disease. Read more about how deCODEme calculates risks.

This test was developed and its performance characteristics determined by the deCODE genetics Diagnostic Laboratory. It has not been cleared or approved by the U. S. Food and Drug Administration (FDA).